Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MDGL compared with PTCT: revenue, margins and what each company keeps, and the suppliers and customers both name
MDGL
Madrigal Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
PTCT
PTC Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MDGL
Madrigal Pharmaceuticals, Inc.
vs
PTCT
PTC Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MDGL, solid
PTCT, dashed
MDGL
Madrigal Pharmaceuticals, Inc.
Change
431.84
▲
+0.34%
Mkt cap
$9.9B
Revenue
$364M
Q2 FY26
Revenue
$958M
FY25
PTCT
PTC Therapeutics, Inc.
Change
59.70
▼
−0.46%
Regular session
Sep 2 '83
Mkt cap
$5.0B
Revenue
$361M
Q2 FY26
Revenue
$1.7B
FY25
vs
Compare
Regular session
Sep 2 '83
MDGL
Madrigal Pharmaceuticals, Inc.
vs
PTCT
PTC Therapeutics, Inc.
431.84
▲
+0.34%
Price
59.70
▼
−0.46%
$9.9B
Mkt cap
$5.0B
Q2 FY26
$364M
Revenue
$361M
Q2 FY26
FY25
$958M
Revenue
$1.7B
FY25
Change
Change
MDGL
431.84
▲
+0.34%
vs
PTCT
59.70
▼
−0.46%
Regular session
Sep 2 '83